Form 4: Opus Genetics SVP Bernhard Hoffmann Reports Stock Disposal
SEC Form 4 Filing
Bernhard Hoffmann, SVP of Corporate Development at Opus Genetics, reported the disposal of 6,751 shares of common stock at a price of $1.14 on February 4, 2025.
Summary
- On February 4, 2025, Bernhard Hoffmann, the SVP of Corporate Development at Opus Genetics, reported a transaction involving the company's common stock.
- Hoffmann disposed of 6,751 shares at a price of $1.14 per share.
- Following the transaction, Hoffmann directly owns 155,946 shares of Opus Genetics common stock.
- The transaction was reported on Form 4, filed with the SEC on February 6, 2025.
Sentiment
Score: 5
Explanation: The document is a routine SEC filing reporting a stock transaction by a company insider. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard practice for company insiders to report transactions in their company's stock, ensuring transparency and compliance with securities regulations.
Stakeholder Impact
- The transaction may have a minor impact on shareholders, potentially influencing the stock price slightly.
Key Dates
| Date | Description |
|---|---|
| 2024-02-01 | Date of Power of Attorney execution. |
| 2025-02-04 | Date of stock transaction. |
| 2025-02-06 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.